Xenter

Alzheimer’s Awareness Month · November 2026

Earlier insights.
Earlier intervention.

Add objective cognitive assessment to your practice: a blood biomarker panel and EEG + ERP, with equipment and a trained technician provided.

Illustration of a brain formed by glowing neural connections

Schedule a workflow walkthrough

Tell us about your practice and your Xenter rep will reach out to set a time.

Please don’t include patient information. By submitting, you agree that Xenter may contact you about the Cognitive Program. See our Privacy Policy.

Why timing matters

Early detection is key.

Earlier identification creates an opportunity to intervene while disease-modifying treatment remains an option.1,2

Two objective measures

Expanding cognitive assessment with pathology and function.

p-tau217 Blood Test

Insight into Alzheimer's pathology.

Measures blood biomarker associated with amyloid pathology to support clinical evaluation.

EEG + ERP

Insight into function.

Measures responses linked to attention, processing, and working memory.

The Xenter Cognitive Program

Built to fit the way your practice already works.

  1. 01

    In your practice

    Equipment and a trained technician provided.

  2. 02

    For your decisions

    Objective reports with complementary insights into brain function and Alzheimer’s pathology.

  3. 03

    In your walkthrough

    Your Xenter rep walks through patient flow, equipment, technician support, and reporting for your practice.

Coding

CPT codes for applicable services*

99483 covers a separate cognitive assessment and care planning service when its requirements are met. Confirm code appropriateness and coverage with your billing team; payment is not guaranteed. Blood biomarker panel billing is not represented by the codes above.

* Providers should confirm the appropriateness and coverage of each CPT selection with their billing team.

92552
Pure tone audiometry
92652
Auditory evoked potentials
95816
Routine EEG
95957
EEG digital analysis
99483
Cognitive assessment and care plan

See how the program fits your practice.

Schedule a walkthrough
Explore Alzheimer’s Association resources

References

1. van Dyck CH, et al. Lecanemab in Early Alzheimer’s Disease. N Engl J Med. 2023;388:9-21. doi:10.1056/NEJMoa2212948.

2. Sims JR, et al. Donanemab in Early Symptomatic Alzheimer Disease. JAMA. 2023;330:512-527. doi:10.1001/jama.2023.13239.

The COGNISION System is for use by qualified clinical professionals in private practice offices or small clinical settings for the acquisition, display, analysis, storage, reporting and management of electroencephalograph (EEG) and auditory evoked potentials (AEP) information.

For educational purposes only; not medical advice. The Xenter Cognitive Assessment is intended to support clinical evaluation by a qualified healthcare provider.